OGT Licenses Southern Array Patents to Taiwan's Phalanx Biotech Group

Nov 01, 2007

NEW YORK (GenomeWeb News) ¯ Oxford Gene Technology yesterday said it has granted Phalanx Biotech Group a license to its Southern array patents.

The deal enables Taiwan-based Phalanx to sell arrays, including its whole-genome OneArray platform, for gene expression-profile studies in the US.

The license is valid for the patents’ lifetime.

Financial details were not disclosed.

Breaking News

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.